| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Li Xu, Huiming Xu, Siqi Chen, Wei Jiang, Shabbir Khan Afridi, Yuge Wang, Xin Ren, Yipeng Zhao, Shuiqing Lai, Xiusheng Qiu, Yu-Wen Alvin Huang, Yaxiong Cui, Hui Yang, Wei Qiu, Changyong Tan. Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases. Molecular therapy : the journal of the American Society of Gene Therapy. 2023-07-23. PMID:37481702. |
neuromyelitis optica (nmo) is an autoimmune inflammatory disease of the central nervous system (cns) characterized by transverse myelitis and optic neuritis. |
2023-07-23 |
2023-08-14 |
mouse |
| Sharon A Sagan, Zahra Moinfar, Carson E Moseley, Ravi Dandekar, Collin M Spencer, Alan S Verkman, Ole Petter Ottersen, Raymond A Sobel, John Sidney, Alessandro Sette, Mark S Anderson, Lawrence Steinman, Michael R Wilson, Joseph J Sabatino, Scott S Zamvi. T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity. Proceedings of the National Academy of Sciences of the United States of America. vol 120. issue 30. 2023-07-18. PMID:37463205. |
aquaporin-4 (aqp4)-specific th17 cells are thought to have a central role in neuromyelitis optica (nmo) pathogenesis. |
2023-07-18 |
2023-08-14 |
Not clear |
| Yachinee Naphattalung, Wanicha Leetiratanai Chuenkongkaew, Niphon Chirapapaisan, Poramaet Laowanapiban, Supattra Sawangku. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review. Annals of medicine. vol 55. issue 1. 2023-06-30. PMID:37387119. |
to appraise whether plasma exchange (plex) effectively improves visual function for acute optic neuritis (on) in neuromyelitis optica (nmo) or neuromyelitis optica spectrum disorder (nmosd). |
2023-06-30 |
2023-08-14 |
Not clear |
| Hesan Jelodari Mamaghani, Zohreh Erfani, Farbod Torkamand, Seyed Mohammad Vahabi, Narges Erfani, Fahimeh Vahabizad, Abdorreza Naser Moghadas. Investigation of sexual dysfunction and depression prevalence in neuromyelitis optica spectrum disorder. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2023-06-29. PMID:37386325. |
to investigate the prevalence of sexual dysfunction (sd) and depression in patients with neuromyelitis optica (nmo), a demyelinating disorder of the central nervous system. |
2023-06-29 |
2023-08-14 |
Not clear |
| Jessica Frau, Giancarlo Coghe, Lorena Lorefice, Giuseppe Fenu, Eleonora Cocc. The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases. Life (Basel, Switzerland). vol 13. issue 6. 2023-06-28. PMID:37374092. |
multiple sclerosis (ms), neuromyelitis optica (nmo) and myelin oligodendrocyte glycoprotein antibody disease (mogad) are inflammatory diseases of the central nervous system (cns) with a multifactorial aetiology. |
2023-06-28 |
2023-08-14 |
human |
| Ibrahim Boukhannous, Anouar El Moudane, Yacoub Ahmed Okiyeh, Mohammed Ramdani, Ali Bark. Neuromyelitis optica in a young patient presenting with urinary retention: A case report. Urology case reports. vol 50. 2023-06-27. PMID:37358990. |
neuromyelitis optica (nmo) is a rare autoimmune disorder of the central nervous system that can cause a variety of neurological symptoms, including urinary dysfunction. |
2023-06-27 |
2023-08-14 |
Not clear |
| Zubir S Rentiya, Ogbonnaya Akuma, Madiha Haseeb, Chinwe C Okonkwo, Dr Aadil Kha. Neuromyelitis Optica: A Case Report From a Radiological Perspective. Cureus. vol 15. issue 5. 2023-06-14. PMID:37313063. |
neuromyelitis optica (nmo), also known as devic's disease, is a chronic inflammatory disorder of the optic nerve and the spinal cord. |
2023-06-14 |
2023-08-14 |
Not clear |
| Turki F Bugshan, Muhannad Asiri, Mohammed Alqahtani, Rayan Maghrabi, Hessah S Alotaibi, Naif Alharb. Neuromyelitis Optica Spectrum Disorder: A Rare Case of Transverse Myelitis and Autonomic Dysfunction. Cureus. vol 15. issue 5. 2023-06-12. PMID:37303442. |
it can present in a relapsing and monophasic pattern and is diagnosed using the diagnostic criteria published in 2015 by the international panel on neuromyelitis optica (nmo) diagnosis. |
2023-06-12 |
2023-08-14 |
Not clear |
| Farrah J Matee. Rectifying global inequities in neuromyelitis optica diagnosis and treatment. Multiple sclerosis (Houndmills, Basingstoke, England). 2023-06-10. PMID:37300419. |
the standard of care for patients with neuromyelitis optica (nmo) has become highly unequal globally. |
2023-06-10 |
2023-08-14 |
Not clear |
| Erika Elizabeth González-Sansores, Brenda Bertado-Cortés, Daniela Alexia León-Castillo, Nallely Rubalcava-Sánche. [Neuromyelitis optica spectrum disorder in a patient with human immunodeficiency virus]. Revista medica del Instituto Mexicano del Seguro Social. vol 61. issue 2. 2023-05-18. PMID:37201182. |
neuromyelitis optica spectrum (nmo) is an autoimmune condition with preferential target at the optic nerves and spinal cord. |
2023-05-18 |
2023-08-14 |
human |
| Ichiro Nakashim. [Therapeutic Strategies for Neuromyelitis Optica]. Brain and nerve = Shinkei kenkyu no shinpo. vol 75. issue 5. 2023-05-17. PMID:37194518. |
treatments for acute attacks of neuromyelitis optica (nmo) include steroid pulse therapy, plasma exchange, and intravenous immunoglobulin. |
2023-05-17 |
2023-08-14 |
Not clear |
| Joe James, V Abdul Gafoor, James Jose, B Smita, Neetha Balara. Therapeutic response to rituximab in seropositive neuromyelitis optica: Experience from a tertiary care center in South India. Journal of neurosciences in rural practice. vol 14. issue 2. 2023-05-15. PMID:37181182. |
neuromyelitis optica (nmo) is a severe central nervous system demyelinating disease caused by autoantibodies to anti-aquaporin-4 immunoglobulin-g (aqp4-igg). |
2023-05-15 |
2023-08-14 |
Not clear |
| Min Cheol Chang, Byung Joo Lee, Dongseok Yang, Chung Reen Kim, Donghwi Park, Sunyoung Ki. The association between cognition and gait disturbance in central nervous system demyelinating disorder with mild disability. BMC neurology. vol 23. issue 1. 2023-04-29. PMID:37120584. |
gait disturbance in central nervous system (cns) demyelinating disorders, including multiple sclerosis (ms) and neuromyelitis optica (nmo) is one of the most troublesome problems that has a direct impact on the quality of life. |
2023-04-29 |
2023-08-14 |
Not clear |
| Danqing Qin, Dong Li, Chunjuan Wang, Shougang Gu. Ferroptosis and central nervous system demyelinating diseases. Journal of neurochemistry. 2023-04-25. PMID:37095635. |
accumulating evidences suggest that brain iron overload is involved in the pathogenesis of demyelinating diseases of the central nervous system (cns), such as multiple sclerosis (ms), neuromyelitis optica (nmo) and acute disseminated encephalomyelitis (adem). |
2023-04-25 |
2023-08-14 |
Not clear |
| André Luiz Guimarães de Queiroz, Herval Ribeiro Soares Neto, Thiago Taya Kobayashi, Sonia Maria Cesar de Azevedo Silv. Plasma exchange in inflammatory demyelinating disorders of the central nervous system: reasonable use in the clinical practice. Arquivos de neuro-psiquiatria. vol 81. issue 3. 2023-04-14. PMID:37059439. |
it mainly modulates the humoral immune system; thus, it has a greater theoretical effect in diseases with prominent humoral mechanisms, such as neuromyelitis optica (nmo). |
2023-04-14 |
2023-08-14 |
Not clear |
| Sven Jarius, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl, Achim Berthele, Katrin Giglhuber, Vivien Häußler, Joachim Havla, Kerstin Hellwig, Martin W Hümmert, Ingo Kleiter, Luisa Klotz, Markus Krumbholz, Tania Kümpfel, Friedemann Paul, Marius Ringelstein, Klemens Ruprecht, Makbule Senel, Jan-Patrick Stellmann, Florian Then Bergh, Hayrettin Tumani, Brigitte Wildemann, Corinna Trebs. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. Journal of neurology. 2023-04-06. PMID:37022481. |
the term 'neuromyelitis optica spectrum disorders' (nmosd) is used as an umbrella term that refers to aquaporin-4 immunoglobulin g (aqp4-igg)-positive neuromyelitis optica (nmo) and its formes frustes and to a number of closely related clinical syndromes without aqp4-igg. |
2023-04-06 |
2023-08-14 |
Not clear |
| Huijing Xu, Yushuang Gong, Yang Jiao, Jian Guo, Ling Zhao, Juechen Yang, Haibin Tong, Meiyan Sun, Miao L. Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4 by the Small Molecule Blocker Melanthioidine. Current pharmaceutical design. 2023-03-31. PMID:36998134. |
neuromyelitis optica (nmo) is a severe neurological demyelinating autoimmune disease affecting the optic nerves and spinal cord. |
2023-03-31 |
2023-08-14 |
Not clear |
| Huijing Xu, Yushuang Gong, Yang Jiao, Jian Guo, Ling Zhao, Juechen Yang, Haibin Tong, Meiyan Sun, Miao L. Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4 by the Small Molecule Blocker Melanthioidine. Current pharmaceutical design. 2023-03-31. PMID:36998134. |
the binding of neuromyelitis optica immunoglobulin g (nmo-igg) and aquaporin-4 (aqp4) on the surface of astrocytes in the serum and cerebrospinal fluid is the main pathogenesis of nmo. |
2023-03-31 |
2023-08-14 |
Not clear |
| Mostafa Manian, Morteza Motallebnezhad, Reza Nedaeinia, Rasoul Salehi, Leila Khani, Gordon A Ferns, Mir Hadi Jazayer. Comparison of OX40 expression in patients with multiple sclerosis and neuromyelitis optica as an approach to diagnosis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. vol 19. issue 1. 2023-03-10. PMID:36899405. |
this study aimed to evaluate the mrna expression of ox40 and its serum levels in the peripheral blood of patients with multiple sclerosis (ms) or neuromyelitis optica (nmo). |
2023-03-10 |
2023-08-14 |
Not clear |
| Thomas Roux, Élisabeth Maillart, Caroline Papei. [Neuromyelitis optica]. La Revue du praticien. vol 73. issue 1. 2023-02-23. PMID:36820464. |
neuromyelitis optica (nmo) or neuromyelitis optica spectrum disorder (nmosd) includes different inflammatory conditions of the central nervous system distinct from multiple sclerosis. |
2023-02-23 |
2023-08-14 |
Not clear |